$83.96
0.29%
NYSE, Oct 05, 04:00 pm EDT. Closed.

U.S. Physical Therapy, Inc. Target price 2026 - Analyst rating & recommendation

U.S. Physical Therapy, Inc. Classifications & Recommendation

Buy
85%
Hold
15%

U.S. Physical Therapy, Inc. Price Target

Target Price $99.96
Price $83.96
Potential
Number of Estimates 8
8 Analysts have issued a price target U.S. Physical Therapy, Inc. 2027 . The average U.S. Physical Therapy, Inc. target price is $99.96. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 11 Analysts recommend U.S. Physical Therapy, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the U.S. Physical Therapy, Inc. stock has an average upside potential 2027 of . Most analysts recommend the U.S. Physical Therapy, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 780.99 863.84
16.33% 10.61%
EBITDA Margin 14.00% 12.28%
6.26% 12.29%
Net Margin 2.76% 5.11%
33.13% 85.02%

9 Analysts have issued a sales forecast U.S. Physical Therapy, Inc. 2026 . The average U.S. Physical Therapy, Inc. sales estimate is

$864m
unlock
. This is
6.36% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$894m 10.02%
unlock
, the lowest is
$822m 1.15%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $781m 16.33%
2026
$864m 10.61%
unlock
2027
$929m 7.52%
unlock
2028
$1.0b 8.42%
unlock

9 Analysts have issued an U.S. Physical Therapy, Inc. EBITDA forecast 2026. The average U.S. Physical Therapy, Inc. EBITDA estimate is

$106m
unlock
. This is
7.36% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$110m 11.48%
unlock
, the lowest is
$101m 2.06%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $109m 23.62%
2026
$106m 2.97%
unlock
2027
$120m 13.51%
unlock
2028
$131m 9.01%
unlock

EBITDA Margin

2025 14.00% 6.26%
2026
12.28% 12.29%
unlock
2027
12.96% 5.54%
unlock
2028
13.04% 0.62%
unlock

9 U.S. Physical Therapy, Inc. Analysts have issued a net profit forecast 2026. The average U.S. Physical Therapy, Inc. net profit estimate is

$44.1m
unlock
. This is
1,557.89% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$49.8m 1,772.93%
unlock
, the lowest is
$39.5m 1,384.21%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $21.6m 22.21%
2026
$44.1m 104.45%
unlock
2027
$52.1m 18.14%
unlock
2028
$56.2m 7.93%
unlock

Net Margin

2025 2.76% 33.13%
2026
5.11% 85.02%
unlock
2027
5.61% 9.78%
unlock
2028
5.58% 0.53%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 1.42 2.96
22.83% 108.45%
P/E 28.32
EV/Sales 1.67

9 Analysts have issued a U.S. Physical Therapy, Inc. forecast for earnings per share. The average U.S. Physical Therapy, Inc. EPS is

$2.96
unlock
. This is
1,544.44% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$3.34 1,755.56%
unlock
, the lowest is
$2.65 1,372.22%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.42 22.83%
2026
$2.96 108.45%
unlock
2027
$3.49 17.91%
unlock
2028
$3.77 8.02%
unlock

P/E ratio

Current 465.11 1,177.10%
2026
28.32 93.91%
unlock
2027
23.98 15.32%
unlock
2028
22.21 7.38%
unlock

Based on analysts' sales estimates for 2026, the U.S. Physical Therapy, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.78 6.81%
2026
1.67 6.06%
unlock
2027
1.56 6.99%
unlock
2028
1.43 7.77%
unlock

P/S ratio

Current 1.54 11.49%
2026
1.45 5.97%
unlock
2027
1.35 7.00%
unlock
2028
1.24 7.77%
unlock

Current U.S. Physical Therapy, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
➜
Locked
Locked Sep 11 2026
Barrington Research
Locked
➜
Locked
Locked Aug 10 2026
Citizens
Locked
➜
Locked
Locked Jun 24 2026
Barrington Research
Locked
➜
Locked
Locked May 13 2026
Citizens
Locked
➜
Locked
Locked May 08 2026
Barrington Research
Locked
➜
Locked
Locked Feb 20 2026
Barrington Research
Locked
➜
Locked
Locked Jan 05 2026
Analyst Rating Date
Locked
JP Morgan:
Locked
➜
Locked
Sep 11 2026
Locked
Barrington Research:
Locked
➜
Locked
Aug 10 2026
Locked
Citizens:
Locked
➜
Locked
Jun 24 2026
Locked
Barrington Research:
Locked
➜
Locked
May 13 2026
Locked
Citizens:
Locked
➜
Locked
May 08 2026
Locked
Barrington Research:
Locked
➜
Locked
Feb 20 2026
Locked
Barrington Research:
Locked
➜
Locked
Jan 05 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today